Roundup Cancer

What is the Roundup lawsuit?

The Roundup lawsuit alleges that Bayer's Monsanto weed killer Roundup (glyphosate) causes non-Hodgkin lymphoma and that the company failed to warn users. Federal cases are consolidated in MDL-2741 before Judge Vince Chhabria in the U.S. District Court for the Northern District of California. A proposed nationwide class settlement has been through state-court approval proceedings, and the U.S. Supreme Court has decided a related failure-to-warn preemption question in Monsanto v. Durnell. Bayer disputes the cancer claims, and Roundup remains on the market.

As of July 1, 2026, Roundup cancer litigation remains active but settlement-focused, with 3,920 actions pending in MDL No. 2741. On June 25, the U.S. Supreme Court held that FIFRA preempted the label-based failure-to-warn claim at issue in Monsanto v. Durnell. The effect on any specific claim depends on the claim's facts and legal theory.

Roundup lawsuits allege that glyphosate-based herbicide exposure may be associated with non-Hodgkin lymphoma and that warnings were inadequate. Claim review usually turns on exposure history, diagnosis records, prior settlement or release paperwork, and state filing deadlines. Defendants dispute the allegations, and this page cannot determine whether any person qualifies for a claim.

Roundup Cancer Lawsuit Update: July 2026

The proposed $7.25 billion nationwide class settlement in King v. Monsanto received preliminary approval in Missouri state court on March 4, 2026. A federal court remanded a related removal attempt back to Missouri state court on June 17. The official settlement website says the fairness hearing originally set for July 9 was rescheduled to August 19, 2026, and that the court has not granted final approval.

On June 25, 2026, the U.S. Supreme Court decided Monsanto Co. v. Durnell (No. 24-1068). The Court held that FIFRA preempted the label-based failure-to-warn claim at issue there. That decision does not itself decide every Roundup claim, including claims based on different facts or legal theories.

As of July 1, 2026, 3,920 actions remained pending in federal MDL No. 2741 before Judge Vince Chhabria. Settlement participation, releases, deadlines, and the legal effect of court rulings remain individual questions.

Case Status Snapshot

• Status: Active / Settlement-focused
• Primary injury: Non-Hodgkin lymphoma
• Main product/exposure: Roundup and other glyphosate-based herbicide products
• MDL or court context: MDL No. 2741, Northern District of California, with related state court and settlement activity
• Settlement status: Proposed class settlement has preliminary approval; fairness hearing listed for August 19, 2026; final approval has not been granted
• Key deadline: Varies by state, diagnosis date, exposure history, discovery facts, prior settlement participation, and court orders
• State law relevance: State law may affect warnings claims, damages, limitations periods, release issues, and wrongful death claims

Who may qualify for a Roundup lawsuit?

Roundup use by itself does not establish that someone has a viable individual lawsuit. A claim review generally considers whether the product and exposure can be identified, whether medical records document non-Hodgkin lymphoma, whether the timeline fits the claim being evaluated, and whether state law or earlier Roundup paperwork affects the person's options.

The proposed King v. Monsanto class uses its own court-defined membership and award rules. Being included in that proposed class is not the same legal question as whether someone can file or continue an individual personal-injury or wrongful-death lawsuit. The official settlement FAQ also treats certain people with pending MDL claims, earlier settlements, releases, judgments, or dismissals differently.

Common individual-claim review factors include:

• Identifiable exposure: The Roundup or glyphosate-containing product, approximate years of use, frequency, duration, and whether exposure occurred at work, at home, or both.
• Exposure circumstances: Applying or mixing the product, cleaning equipment, handling concentrate, spills, overspray, skin contact, inhalation, and protective equipment.
• Documented diagnosis: Pathology and oncology records showing non-Hodgkin lymphoma, the subtype, diagnosis date, treatment, recurrence, or death where relevant.
• Complete timeline: First and last exposure, diagnosis, treatment, recurrence, death, and the date the person first connected the diagnosis with the alleged exposure.
• Prior legal activity: Earlier lawsuits, tolling agreements, settlements, releases, judgments, dismissals, class notices, or opt-out paperwork.
• Applicable law: The state and claim type that may control filing deadlines, available legal theories, and wrongful-death or survival issues.

Agricultural work, landscaping, groundskeeping, nursery work, golf-course maintenance, municipal weed control, parks or school maintenance, and repeated homeowner use can produce different exposure records. These factors help organize a review; they are not an automatic qualification formula, and this site cannot decide whether a person has a claim.

Litigation Updates and Timeline

• 2016: Federal Roundup cases were centralized in MDL No. 2741 in the Northern District of California for coordinated pretrial proceedings.
• 2018-2020: Early trials, appeals, and settlement discussions shaped the national litigation and brought broader attention to glyphosate-related non-Hodgkin lymphoma claims.
• 2020-2025: Many claims moved through settlement programs, state court proceedings, appeals, and continuing disputes over warnings and causation.
• February 2026: Public reports described a proposed multibillion-dollar Roundup settlement intended to address large groups of current and future claims, subject to court process and objections.
• May 2026: Public reports described legal disputes that could affect settlement timing, approval, deadlines, or the forum handling settlement-related issues.

When did the Roundup lawsuit start?

For people asking when the Roundup lawsuit started, there are two useful ways to think about the timeline. Individual product use and cancer diagnoses may date back many years, while the federal Roundup multidistrict litigation became a centralized national proceeding in 2016. That federal coordination is important because it helped organize common pretrial issues in many Roundup product liability cases.

The broader litigation has continued through trials, appeals, settlement programs, state court activity, and ongoing disputes over warnings, causation, preemption, releases, and settlement procedures. Because the litigation has a long history, a current claim review may need to look backward at exposure years, diagnosis date, prior claim participation, and whether any settlement or release paperwork already exists.

The start date of the litigation does not answer whether a claim is timely. A person diagnosed years ago may face different deadline questions than someone with a more recent diagnosis, and those questions may depend on state law and individual discovery facts.

Current litigation status

Roundup cancer claims remain active, although the litigation is more mature than some newer mass torts. Federal Roundup product liability cases have long been coordinated in MDL No. 2741 in the Northern District of California, and many claims have also proceeded in state courts or settlement programs.

The litigation involves allegations that exposure to Roundup or other glyphosate-based herbicides is associated with non-Hodgkin lymphoma and that warnings were inadequate. Defendants dispute causation, warning, liability, and damages issues. Because Roundup litigation includes federal proceedings, state court trials, appeals, settlement activity, and ongoing legal disputes, status can change quickly. This guide is a general overview rather than a live docket report.

Key issues in the lawsuit

Roundup lawsuits generally focus on whether repeated exposure to glyphosate-based herbicides can be linked to non-Hodgkin lymphoma and whether Monsanto or related defendants adequately warned users about alleged cancer risks. Plaintiffs may include agricultural workers, landscapers, groundskeepers, homeowners, nursery workers, parks employees, school or municipal workers, and others who used or handled Roundup repeatedly.

The key factual issues include how often the person used Roundup, whether exposure was occupational or residential, whether the person mixed concentrate or used ready-to-use products, what protective equipment was used, and whether the diagnosis is a type of non-Hodgkin lymphoma being evaluated. Legal issues may include warning adequacy, causation, federal preemption arguments, state-law deadlines, settlement releases, and proof of damages.

Defendants may argue that regulatory labeling was adequate, that scientific evidence does not prove causation for a particular person, that exposure was too limited, or that other risk factors explain the cancer. Plaintiffs may point to repeated use, product history, diagnosis records, and expert causation evidence.

Roundup claims can also turn on the difference between casual product use and repeated exposure. A homeowner who sprayed weeds once or twice may present a different review than a worker who mixed concentrate, sprayed large areas, cleaned equipment, or handled the product as part of routine job duties over many seasons.

What proof do you need for a Roundup lawsuit?

No single receipt, photograph, or medical record proves that someone qualifies. A useful review usually combines evidence identifying the product and exposure with records confirming the diagnosis and dates that may control timeliness.

• Product and exposure records: Purchase receipts, product or container photographs, EPA registration numbers, application logs, invoices, farm records, property-maintenance records, job descriptions, payroll records, employer records, and witness statements.
• Exposure details: Approximate first and last use, frequency, hours or days of use, whether concentrate was mixed, tasks performed, protective equipment, and whether exposure occurred at work or home.
• Medical records: Pathology reports, biopsy results, oncology records, records naming the lymphoma subtype, treatment records, recurrence records, and death records where applicable.
• Timing and legal documents: Diagnosis and treatment dates plus any lawsuit, tolling agreement, settlement, release, judgment, dismissal, class notice, or opt-out record.

Missing receipts do not automatically decide the issue. Other records may help document product use, but vague memories or unidentified weed-killer exposure can make review more difficult. A person gathering records should preserve the originals and avoid guessing at dates or product names.

When will Roundup settlements be paid?

There is no single payment date for all Roundup claims. Earlier settlements, individual state-court cases, MDL cases, and the proposed 2026 nationwide class settlement may follow different timelines. The official settlement website lists an August 19, 2026 fairness hearing and says final approval has not been granted. Any final order, appeal, eligibility review, claim administration, release, and individual documentation can affect timing.

For individual claims, a payment timeline may depend on whether the claim is already resolved, whether a release was signed, whether lien resolution is required, and whether the person is participating in a specific settlement program. Search results that promise a universal payout date should be treated cautiously unless they cite the settlement administrator, court order, or docket.

What is the deadline to file a Roundup lawsuit?

There is no single national deadline for an individual Roundup lawsuit. A filing deadline may depend on the governing state's statute of limitations or repose, the legal claim, diagnosis and discovery facts, a death date in wrongful-death or survival matters, and any earlier lawsuit, tolling agreement, settlement, release, judgment, or dismissal.

The federal MDL does not create one filing period for every person nationwide. Questions about whether time runs from product use, symptoms, diagnosis, discovery, or death require state-specific legal analysis. Because Roundup litigation has been public for years, waiting to identify the relevant dates can create additional risk.

Class-settlement dates do not replace an individual lawsuit deadline. The proposed King v. Monsanto settlement has a separate court-controlled schedule. Its official website says the June 4, 2026 deadline to object or request exclusion has passed, the fairness hearing is scheduled for August 19, 2026, and registration and claim submission are not yet open because final approval has not been granted.

If the proposed settlement receives final approval and becomes effective, people who are class members and did not opt out may be bound by its release and may lose the ability to pursue covered claims outside the settlement program, subject to the settlement's terms and exceptions. That possible consequence is separate from whether a state statute of limitations has expired.

The proposed class also describes later registration and claim-submission periods if the settlement becomes final. Those program dates concern settlement participation; they do not establish whether an individual personal-injury, wrongful-death, or survival claim was timely filed under applicable state law.

To prepare for a deadline review, gather the earliest supportable dates for:

• first and last Roundup or glyphosate-product exposure;
• symptoms, diagnosis, pathology, treatment, and recurrence;
• death and appointment of an estate representative, where applicable;
• states where exposure, residence, diagnosis, and treatment occurred; and
• prior claims, tolling agreements, settlements, releases, judgments, dismissals, or class notices.

The state guide links on this page provide general state context, but they cannot calculate a deadline for a particular person. A licensed attorney must determine which law and date apply.

Questions to ask before contacting a lawyer

• Can I identify the Roundup or glyphosate product I used?
• Was my exposure occupational, residential, agricultural, or landscaping-related?
• How often did I apply the product, and for how many years?
• What type of non-Hodgkin lymphoma was diagnosed, and when?
• Have I signed any settlement, release, or claim paperwork before?
• Which state deadline rules may apply to my exposure and diagnosis timeline?

Sources and status notes

• Federal court context: Federal Roundup product liability cases have been coordinated in MDL No. 2741 in the Northern District of California, with related state-court and settlement activity.
• Agency or medical context: Public context may involve glyphosate regulatory materials, product-labeling issues, and court materials addressing warnings, causation, settlement, and appeal issues. EPA maintains public information on glyphosate.
• Litigation status: This guide summarizes public litigation status information and should not be treated as a live court docket. Roundup litigation is mature and settlement-focused compared with newer mass torts, but individual claim status remains fact-specific.
• Supreme Court ruling: The Monsanto Co. v. Durnell opinion was issued June 25, 2026.
• Proposed class settlement: The official settlement website lists the current hearing date and approval status.
• Class definitions and options: The official settlement site's frequently asked questions explain the proposed class definition, the treatment of pending MDL plaintiffs, and the settlement-specific deadlines.
• Review note: Case status, settlement posture, deadlines, and eligibility factors can change.
• Last reviewed: July 21, 2026.

Where can I track the Roundup Cancer lawsuit?

Use the mass tort settlement tracker to compare public settlement posture, the deadline tracker for filing-window and key-date notes , and the MDL statistics tracker for federal case counts and court assignments.

What injuries does the Roundup Cancer lawsuit involve?

• Non-Hodgkin lymphoma
• Glyphosate exposure
• Agricultural exposure
• Landscaping or groundskeeping exposure

What evidence is needed for Roundup Cancer claims?

• Product use history
• Employment or groundskeeping records
• Purchase records
• Medical diagnosis records
• Oncology records
• Treatment records

How has the Roundup Cancer lawsuit progressed?

What is the Roundup Cancer settlement status?

A proposed $7.25 billion nationwide class settlement received preliminary approval in King v. Monsanto. The official settlement website says the fairness hearing was rescheduled to August 19, 2026, and final approval has not been granted. That proposed class settlement is separate from earlier individual settlements and verdicts. Individual options may depend on diagnosis type, exposure history, prior settlement paperwork, opt-out or release issues, state deadlines, and ongoing court rulings; no recovery is guaranteed.

What are the Roundup Cancer lawsuit filing deadlines?

Deadlines vary by state and may depend on diagnosis date, discovery date, exposure history, wrongful death issues, and other facts. A lawyer can evaluate how the relevant deadline rules may apply.

State-by-state guide links